FITYFifty 1 Labs Inc.

About Fifty 1 Labs Inc. (FITY)

Fifty 1 Labs Inc. (FITY) is a Credit Services company headquartered in Melbourne, FL, United States whose shares trade over-the-counter on the Pink tier.

Fifty 1 Labs, Inc., a Nevada corporation, is a holding company driving innovation in health, wellness, and biotechnology. FITY owns 100% of Genetic Networks LLC, a Delaware-based biotech firm founded in 2015 by Dr. Gennaro D’Urso. Genetic Networks, headquartered in Miami, Florida, develops the GeneScape™ platform, a yeast-based, whole-genome analysis tool that accelerates drug discovery for personalized medicine, biodefense, and wellness applications, with proven success serving major pharma clients like Bristol Myers Squibb. FITY also wholly owns 51, LLC, its sports nutrition subsidiary offering a premium line of supplements—including pre-workout formulas, BCAAs, ION+ Electrolyte Formula, Turmeric Gummies, and Ashwagandha Gummies—designed to enhance athletic performance, recovery, and overall health.

Products and services

Whole-genome analysis platform tool that accelerates drug discovery for personalized medicine, biodefense, and wellness applications. Premium line of supplements - including pre-workout formulas, BCAAs, ION+Electrolyte Formulas, Turmeric Gummies, and Ashwagandha Gummies.

FITY key facts

Ticker symbol

FITY

Market tier

Pink

Sector

Financial Services

Industry

Credit Services

Headquarters

Melbourne, FL, United States

Country of incorporation

US

Year of incorporation

2001

Employees

2

Estimated market cap

$800.6K (as of Apr 9, 2025)

Shares outstanding

571,878,600

Reporting standard

Alternative Reporting Standard

Audit status

Unaudited

Fiscal year end

6/30

Latest filing

Quarterly Report (Dec 31, 2024)

Fifty 1 Labs Inc. leadership

• Gennaro D'Urso — CEO
• Brandon Spikes — President, Company Secretary

Explore more: Credit Services stocks · Financial Services sector · Pink stocks · OTC stocks starting with F